Xolair 75 MG/0.5 ML autoinject 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FX1KQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,554
Award facts
- Contract value 100% obligated
- $2,554.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,554.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 ml auto-injector units. The delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 contract awarded on November 13, 2025, that positions the company as a critical supplier of pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide.
The PPV-G GEN V program represents part of the Defense Logistics Agency's $30.3 billion acquisition strategy to establish multiple regional prime vendor contractors capable of supplying comprehensive pharmaceutical inventories including branded and generic prescription drugs, biologics, vaccines, and specialty pharmaceuticals to military medical facilities globally. DMS Pharmaceutical Group's established performance across diverse product categories and its demonstrated capability to manage numerous delivery orders without subcontractors underscores its role as a key pharmaceutical supplier within the federal military medical supply chain, with the Xolair delivery order exemplifying the routine procurement activities executed under this strategic vendor agreement.
Quick answers
Who was awarded contract SPE2DB26FX1KQ?
SPE2DB26FX1KQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FX1KQ worth?
The government has obligated $2,554 on SPE2DB26FX1KQ.
Is contract SPE2DB26FX1KQ an order under another contract?
Yes. SPE2DB26FX1KQ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1KQ competed?
The extent of competition for SPE2DB26FX1KQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award